Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04520360 · ClinicalTrials.gov registry record · Phase 1
Bioavailability and Food Effect Study of 3 Types of Carisbamate
A Phase 1 study of Healthy Subjects, sponsored by SK Life Science.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT04520360 is a Phase 1 study of Healthy Subjects that has completed, run by SK Life Science. The registered enrollment target is 33 participants, below the 128-participant average among 69 other Healthy Subjects trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04520360, a Phase 1 study of Healthy Subjects, has completed, sponsored by SK Life Science.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to examine the relative bioavailability of three carisbamate formulations (Oral Suspension Type 1, Oral Suspension Type 2, and a 300 mg Oral Tablet) and to assess the effect of food on the oral bioavailability of the Oral Suspension Type 2 and the 300 mg Oral Tablet.
Conditions Studied
Interventions
- DRUG Carisbamate
Study Locations (1)
Utah
- PRA Health Sciences- Salt Lake City - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2020-08-27 |
| Est. Completion | 2021-10-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04520360
The ClinicalTrials.gov registry entry for NCT04520360 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 128-participant average among 69 other Healthy Subjects trials with a reported enrollment target (74% lower). The listed sponsor is SK Life Science, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Subjects appearing as the primary indexed condition, and to 1 intervention - of which Carisbamate is the first listed.
NCT04520360 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT04520360 about?
NCT04520360 is a clinical study titled "Bioavailability and Food Effect Study of 3 Types of Carisbamate". This study is designed to examine the relative bioavailability of three carisbamate formulations (Oral Suspension Type 1, Oral Suspension Type 2, and a 300 mg Oral Tablet) and to assess the effect of food on the oral bioavailability of the Oral Suspension Type 2 and the 300 mg Oral Tablet.
What is the current status of trial NCT04520360?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2020-08-27. Estimated completion is 2021-10-06.
What conditions does trial NCT04520360 study?
This clinical trial studies the following conditions: Healthy Subjects.
What interventions are being tested in trial NCT04520360?
The interventions under investigation include: Carisbamate (DRUG).
Who is sponsoring clinical trial NCT04520360?
This trial is sponsored by SK Life Science, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04520360 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Subjects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase I Study of ICP-332 in Healthy Subjects
RECRUITING · Phase 1
-
A Study to Investigate HLA-G Targeted Exosome (SOB100) in Healthy Subjects
RECRUITING · Phase 1
-
Phase 1 Study of Intravaginal KB15A
RECRUITING · Phase 1
-
A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations
COMPLETED · Phase 1
-
Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol®
COMPLETED · Phase 1
-
A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.